Related Experiment Video
Updated: Jul 1, 2026
08:20
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
[What is needed for rTMS to become a treatment?]
J R Foucher1, D Luck, S Chassagnon
1Clinique psychiatrique, Inserm U666, hôpitaux universitaires, B.P. 406, 67091 Strasbourg cedex, France. jf@evc.net
L'Encephale
|September 16, 2008
Summary
Repetitive transcranial magnetic stimulation (rTMS) shows promise for treating conditions like depression but faces challenges. Improving stimulation precision and protocol optimization are key to enhancing rTMS efficacy and reliability for therapeutic applications.
Area of Science:
- Neuroscience
- Neuromodulation
Context:
- Repetitive transcranial magnetic stimulation (rTMS) modulates cortical excitability, showing potential for treating depression and hallucinations.
- Current therapeutic application of rTMS is limited by short-lasting and inconsistent effects across patients.
Purpose:
- To discuss factors influencing rTMS efficacy and explore options for more efficient protocols.
- To highlight the need for improved control over stimulation site and coil placement using functional imaging and neuronavigation.
Summary:
- rTMS effects are short-lived and variable due to factors like inadequate stimulation site control and inconsistent protocol parameters (frequency, intensity, number of stimuli).
- Individualized stimulation site localization using functional imaging and accurate coil placement via neuronavigation are crucial.
- Optimizing stimulation patterns, conditioning, cortical state, and considering patient-specific factors can enhance rTMS reliability and effect amplification.
Impact:
- Provides a review of physiological literature to establish a rational basis for developing more effective rTMS protocols.
- Aims to improve the therapeutic utility of rTMS by addressing current limitations in efficacy and consistency.
More Related Videos
Related Concept Videos
01:52Regression Toward the Mean
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.